Just eight months after undergoing robotic surgery to remove his cancerous prostate, Mark Cwiek, a 70-year-old track and ...

Sherrie Wood and her husband, Kenneth, were newly married when he was diagnosed with prostate cancer in 2003. He experienced ...

NEW YORK – The US Food and Drug Administration on Friday expanded the indication for Novartis' radioligand therapy Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for use prior to chemotherapy in ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...

Some recommend scoring solid intraductal carcinoma as Gleason 5, but the cancer is linked to significantly poorer outcomes.

The first step is often a blood test for prostate-specific antigen (PSA). If ... Dec. 16, 2024 — Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer ...

Assessment of prostate-specific antigen (PSA) level for three months after radical prostatectomy (RP) for prostate ...

According to investigators, there is no validated PSA-based endpoint to compare oncologic outcomes after radical prostatectomy and radiation therapy for localized prostate cancer.

Men who avoided prostate cancer screening appointments were significantly more likely to die from the disease, according to ...

PET/CT scans using an experimental prostate-specific membrane antigen (PSMA) imaging agent can identify SC nodal metastasis ...

Men who avoided prostate cancer screening were significantly more likely to die from the disease, according to a large ...